Entheon Biomedical Corp

OTCQB:ENTBF USA Biotechnology

Market Cap

$1.23 Million

Market Cap Rank

#36071 Global

#11733 in USA

Share Price

$0.09

Change (1 day)

+0.00%

52-Week Range

$0.06 - $0.12

All Time High

$9.90

Entheon Biomedical Corp - Asset Resilience Ratio

Latest as of September 2021: 0.00%

Entheon Biomedical Corp (ENTBF) has an Asset Resilience Ratio of 0.00% as of September 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$0.00

Cash + Short-term Investments

Total Assets

$9.98 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2022)

This chart shows how Entheon Biomedical Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Entheon Biomedical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$0.00	0%
Total Liquid Assets	$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Entheon Biomedical Corp maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.